BioSpace News Archive

Signature comedy fundraiser helps to fund stomach cancer research.

Phase 2 study will Examine the Effect of Mavrilimumab on the Clinical Profile of Yescarta

NeuroTracker was selected among 750 emerging tech companies in the digital health space.

The Alliance for Regenerative Medicine, the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, announced its 2020 Cell & Gene Therapies State of the Industry briefing will take place January 13, 2020 in San Francisco, held in conjunction with Biotech Showcase™ 2020.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointment of Dr. Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology (NGIO) Board of Directors.

A new study to be published in the American Journal of Kidney Diseases provides evidence that coffee consumption has beneficial effects on kidney function and could potentially be used in prevention strategies.

Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today announced that a hearing date has not yet been scheduled for consideration of the Company’s application materials, filed on November 18, 2019 with the Supreme Court of British Columbia (the “Court”), relating to Court orders sought by the Company in connection with the Company’s voluntary liquidation and dissolution (the “Liquidation”).

BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice of Intention to Make a Normal Course Issuer Bid (the “NCIB”)

Sildenafil Cream, 3.6% has the Potential to Be the First FDA-Approved Product for FSAD

Patients Canada is pleased to announce that Francesca Grosso has been appointed as the Chair of Patients Canada